Gemcitabine
- 1 January 2005
- journal article
- Published by Springer Science and Business Media LLC in American Journal of Cancer
- Vol. 4 (6), 395-416
- https://doi.org/10.2165/00024669-200504060-00006
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A phase III trial of pemetrexed plus gemcitabine versus gemcitabine in patients with unresectable or metastatic pancreatic cancerAnnals of Oncology, 2005
- Comparative Pharmacokinetics and Metabolic Pathway of Gemcitabine During Intravenous and Intra-arterial Delivery in Unresectable Pancreatic Cancer PatientsClinical Pharmacokinetics, 2005
- Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic CancerOncology, 2004
- Raltitrexed plus Gemcitabine (TOMGEM) in Advanced Pancreatic CancerOncology, 2004
- Phase III Study of Gemcitabine in Combination With Fluorouracil Versus Gemcitabine Alone in Patients With Advanced Pancreatic Carcinoma: Eastern Cooperative Oncology Group Trial E2297Journal of Clinical Oncology, 2002
- Gemcitabine alone or with cisplatin for the treatment of patients with locally advanced and/or metastatic pancreatic carcinomaCancer, 2002
- Phase II Study of Gemcitabine, UFT and Leucovorin in Patients with Advanced Pancreatic CancerActa Oncologica, 2002
- Marimastat as First-Line Therapy for Patients With Unresectable Pancreatic Cancer: A Randomized TrialJournal of Clinical Oncology, 2001
- Phase II trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinomaCancer, 2000
- Phase I and Pharmacokinetic Trial of Gemcitabine in Patients With Hepatic or Renal Dysfunction: Cancer and Leukemia Group B 9565Journal of Clinical Oncology, 2000